In the immune cell, inhibition of GSK-3 has been shown to downregulate programmed cell death protein 1 (PD-1) expression in CD8+ T cells to enhance CD8+ cytotoxic function in a murine model, resulting in reduced tumor growth [7]. Here, CD8A is linked to neoplasm.